Evidence map›Paper›PMID 27318131›Full record

ArticleNeurobiology of aging2016

Insensitivity of astrocytes to interleukin 10 signaling following peripheral immune challenge results in prolonged microglial activation in the aged brain.

Diana M Norden, Paige J Trojanowski, Frederick R Walker, Jonathan P Godbout

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of aging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. IL-1ra and CCL5, but not IL-10, are promising targets for treating SMA astrocyte-driven pathology.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  9. Adolescent Alcohol and the Spectrum of Cognitive Dysfunction in Aging.Advances in experimental medicine and biology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Vancomycin Pretreatment on MPTP-Induced Parkinson's Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2023
    Article
  17. Article
  18. International journal of molecular sciences · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Diana M NordenDepartment of Neuroscience, The Ohio State University, Columbus, OH, USA.
Paige J TrojanowskiDepartment of Neuroscience, The Ohio State University, Columbus, OH, USA.
Frederick R WalkerSchool of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, South Wales, Australia.
Jonathan P GodboutDepartment of Neuroscience, The Ohio State University, Columbus, OH, USA; Center for Brain and Spinal Cord Repair, The Ohio State University, Columbus, OH, USA; Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA. Electronic address: jonathan.godbout@osumc.edu.
The Ohio State University · USUniversity of Newcastle Australia · AU

Funding

Consequences of Age-Related Impairments in the Dynamic Regulation of Active Microglia by AstrocytesR01AG051902 · NIA · OHIO STATE UNIVERSITY · PI GODBOUT, JONATHAN P · 2016 to 2020
$2.1M
Aging, Microglial Dysregulation and DepressionR01AG033028 · NIA · OHIO STATE UNIVERSITY · PI GODBOUT, JONATHAN P · 2009 to 2013
$1.5M
NIA NIH HHS R01 AG033028NIA NIH HHS R01 AG051902
6 · The paper itself

Abstract

Immune-activated microglia from aged mice produce exaggerated levels of cytokines. Despite high levels of microglial interleukin (IL)-10 in the aged brain, neuroinflammation was prolonged and associated with depressive-like deficits. Because astrocytes respond to IL-10 and, in turn, attenuate microglial activation, we investigated if astrocyte-mediated resolution of microglial activation was impaired with age. Here, aged astrocytes had a dysfunctional profile with higher glial fibrillary acidic protein, lower glutamate transporter expression, and significant cytoskeletal re-arrangement. Moreover, aged astrocytes had reduced expression of growth factors and IL-10 receptor-1 (IL-10R1). After in vivo lipopolysaccharide immune challenge, aged astrocytes had a molecular signature associated with reduced responsiveness to IL-10. This IL-10 insensitivity of aged astrocytes resulted in a failure to induce IL-10R1 and transforming growth factor β and resolve microglial activation. In addition, adult astrocytes reduced microglial activation when co-cultured ex vivo, whereas aged astrocytes did not. Consistent with the aging studies, IL-10R(KO) astrocytes did not augment transforming growth factor β after immune challenge and failed to resolve microglial activation. Collectively, a major cytokine-regulatory loop between activated microglia and astrocytes is impaired in the aged brain.

Indexed as

AgingAmino Acid Transport System X-AGAnimalsAstrocytesBrainCells, CulturedCoculture TechniquesGlial Fibrillary Acidic ProteinInterleukin-10Interleukin-10 Receptor alpha SubunitLipopolysaccharidesMice, Inbred BALB CMice, Inbred C57BLMicrogliaSignal TransductionTransforming Growth Factor betaAmino Acid Transport System X-AGGlial Fibrillary Acidic ProteinInterleukin-10Interleukin-10 Receptor alpha SubunitLipopolysaccharidesTransforming Growth Factor betaAgingAstrocyteInterleukin-10MicrogliaNeuroinflammationTGF-beta

Identifiers

PMID27318131
PMCPMC5467746
OpenAlexW2343167511

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.